20 June 2017

Merck Ventures and CRUK launch new immuno-oncology spinout iOnctura

German Merck and R&D charity CRUK are coming together to launch a biotech focused on immuno-oncology. The company, called iOnctura, has come to life via its venture arm Merck Ventures and is formed around two assets from the pipeline of Merck and three assets from Cancer Research Technology (CRT), the commercial arm of London’s Cancer Research U.K. (CRUK). Source: Fierce Biotech 20/6/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).